MONOCLONAL ANTI-IL-2 RECEPTOR ANTIBODY IN PRIMATE RENAL-TRANSPLANTATION

被引：0
|
作者：
SHAPIRO, ME
KIRKMAN, RL
REED, MH
PUSKAS, JD
MAZOUJIAN, G
LETVIN, NL
CARPENTER, CB
MILFORD, EL
WALDMANN, TA
STROM, TB
SCHLOSSMAN, SF
机构：
[1] NEW ENGLAND REG PRIMATE RES CTR,DANA FARBER CANC INST,SOUTHBOROUGH,MA 01772
[2] BETH ISRAEL HOSP,DEPT SURG,BOSTON,MA 02215
[3] BETH ISRAEL HOSP,DEPT MED,BOSTON,MA 02215
[4] BETH ISRAEL HOSP,DEPT PATHOL,BOSTON,MA 02215
[5] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[6] NCI,METAB BRANCH,BETHESDA,MD 20205
来源：
TRANSPLANTATION PROCEEDINGS | 1987年 / 19卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：594 / 598
页数：5
相关论文
共 50 条
  • [31] ANTI-VASCULAR ENDOTHELIUM ANTIBODY IN RENAL-TRANSPLANTATION
    CERILLI, GJ
    HOLLIDAY, JE
    LEE, IC
    SURGICAL FORUM, 1975, 26 : 341 - 342
  • [32] Anti-IL-2 receptor antibody decreases cytokine-induced apoptosis of human renal tubular epithelial cells (TEC)
    Wang, Shuang
    Zhang, Zhu-Xu
    Yin, Ziqin
    Liu, Weihua
    Garcia, Bertha
    Huang, Xuyan
    Acott, Philip
    Jevnikar, Anthony M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2144 - 2153
  • [33] THE ROLE OF A PRIMATE MODEL OF RENAL-TRANSPLANTATION IN THE DEVELOPMENT OF NEW MONOCLONAL-ANTIBODIES
    SHAPIRO, ME
    REED, MH
    STROM, TB
    CARPENTER, CB
    MILFORD, EL
    KIRKMAN, RL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (05) : 58 - 60
  • [34] Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal, anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans
    Van Gelder, T
    Baan, CC
    Balk, AHMM
    Knoop, CJ
    Holweg, CTJ
    Van der Meer, P
    Mochtar, B
    Zondervan, PE
    Niesters, HGM
    Weimar, W
    TRANSPLANTATION, 1998, 65 (03) : 405 - 410
  • [35] Anti-IL-2 Receptor Antibodies versus Anti-Thymocyte Globulin for Induction Therapy in Kidney Transplantation
    Mandelbrot, Didier
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (06): : 1170 - 1171
  • [36] MONOCLONAL ANTI-IL2-RECEPTOR IN ORGAN-TRANSPLANTATION
    SOULILLOU, JP
    JACQUES, Y
    TRANSPLANT INTERNATIONAL, 1989, 2 (01) : 46 - 52
  • [37] PROPHYLACTIC USE OF THE IL-2 RECEPTOR-SPECIFIC MONOCLONAL-ANTIBODY LO-TACT-1 WITH CYCLOSPORINE-A AND STEROIDS IN RENAL-TRANSPLANTATION
    HIESSE, C
    KRIAA, F
    ALARD, P
    LANTZ, O
    NOURY, J
    BENSADOUN, H
    BENOIT, G
    CHARPENTIER, B
    FRIES, D
    BAZIN, H
    TRANSPLANT INTERNATIONAL, 1992, 5 : S444 - S447
  • [38] ANTI-REJECTION THERAPY IN RENAL-TRANSPLANTATION - USE OF THE MONOCLONAL-ANTIBODY OKT3
    NICHOLSON, ML
    DONNELLY, PK
    VEITCH, PS
    BELL, PRF
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (04) : 275 - 279
  • [39] STUDIES ON LYMPHOCYTE-T ACTIVATION .2. MONOCLONAL-ANTIBODY INHIBITING THE CAPACITY OF RAT LYMPHOBLASTS-T TO ABSORB AND TO RESPOND TO IL-2 - AN ANTI-IL-2 RECEPTOR ANTIBODY
    OSAWA, H
    DIAMANTSTEIN, T
    IMMUNOLOGY, 1983, 48 (03) : 617 - 621
  • [40] Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor α therapy:: A prospective, randomized, multicenter study
    ter Meulen, CG
    van Riemsdijk, I
    Hené, RJ
    Christiaans, MHL
    Borm, GF
    van Gelder, T
    Hilbrands, LB
    Weimar, W
    Hoitsma, AJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 803 - 810
12345